valnoctamide has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basselin, M; Modi, HR; Rapoport, SI | 1 |
| Chang, L; Chen, M; Ma, K; Modi, HR; Rapoport, SI | 1 |
2 other study(ies) available for valnoctamide and arachidonic acid
| Article | Year |
|---|---|
Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.
Topics: Amides; Arachidonic Acid; Coenzyme A Ligases; Dose-Response Relationship, Drug; Enzyme Activation; In Vitro Techniques; Iodine Isotopes; Models, Statistical; Valproic Acid | 2014 |
Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.
Topics: Amides; Animals; Antimanic Agents; Arachidonic Acid; Bipolar Disorder; Brain; Male; Phospholipids; Rats | 2017 |